V VALNEVA
LIVE

Serial Number

79156199

Owner

VALNEVA

Attorney

Christina M. Licursi

Filing Date

Jul 16, 2014

Add to watchlist:

No watchlists yet
View on USPTO

V VALNEVA Trademark

Serial Number: 79156199 • Registration: 4774813

V VALNEVA is a trademark filed by VALNEVA on July 16, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VALNEVA (5 trademarks)

6 rue Alain Bombard

Entity Type: 99

Trademark Details

Filing Date

July 16, 2014

Registration Date

July 21, 2015

Published for Opposition

May 5, 2015

Goods & Services

Pharmaceutical products for human and veterinary use for the treatment of auto immune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; medical, biological, biotechnological, protein, virological, immunological, bacteriological, chemical, enzymatic and pharmaceutical preparations for medical and veterinary use; medical, biological, biotechnological, protein, virological, immunological, bacteriological, chemical, enzymatic and pharmaceutical products, namely, preparation of encapsulated cells which release antibodies for medical and veterinary use; diagnostic products, namely, diagnostic preparations for use in human, veterinary medicine and pharmaceutical use; cell, microorganism or virus cultures for medical and veterinary use; adjuvants for medical or veterinary use; antibiotics, vaccines, viruses, viral vectors, nucleic acids, proteins, recombinant proteins, peptides, peptide antigens, blood serum, antibodies and fragments thereof, and cells for medical, pharmaceutical and veterinary use; viral substances, immunological substances, bacterial substances, enzyme substances used for human and veterinary medicine; diagnostic kits consisting primarily of antibodies and fragments thereof for use in disease testing; diagnostic kits primarily of antibodies and antibody fragments for use in disease testing

Chemical products, namely, fungicides, herbicides, insecticides and parasiticides for use in industry, science as well as in agriculture; molecules from bio technologies, namely, proteins in raw material for scientific and medical research; cells for scientific, laboratory or medical research; cell lines for scientific and medical research; nucleic acids for laboratory use; proteins for industrial use; recombinant proteins for industrial use; biomedical compounds, namely, peptides substrates; peptide antigens used in analyzing and detecting certain toxins for research, clinical, medical laboratory use; Biochemical preparations derived from blood serum for use in scientific and medical research; Bio chemicals, namely, antibodies and fragments thereof for in vitro scientific or research use, Chemicals for use in biotechnological product development; cultures of microorganisms other than for medical and veterinary use; viruses, cells, biological, bacteriological or viral preparations, other than for nucleic acids for scientific, laboratory, or medical research

Scientific research services for medical purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous systems, cardiovascular diseases, neurodegenerative and chronic diseases; scientific and industrial research, in particular in the fields of biology, cellular and molecular biology, biotechnology, bacteriology, immunology, genetics, gene study, medicine, pharmacology, virology, chemistry; scientific research relating to vaccines, antibiotics and immunological products for human and veterinary use; research and development of new products for others; testing and evaluations of the goods of others to assure compliance with industry standards in the scientific, medical and veterinary fields; research and development of new products for human and veterinary use; scientific research, namely, preparation of scientific experts opinion reports in the scientific, medical and veterinary fields; development and design of laboratory instruments for scientific and industrial research, in particular to obtain and prepare cells, cell lines, viruses, proteins, animal and human materials; development of vaccines, antibiotics and immunological products for human and veterinary use; scientific and technological services, namely, diagnostic and prognostic analyses in the fields of cells, cell lines, animal and human materials, microorganisms, molecules for scientific purposes; scientific research, namely, preparation of scientific expert opinions reports

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 12, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Aug 12, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 29, 2025 APRE
TEAS SECTION 71 RECEIVED
May 12, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jul 21, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
Jun 7, 2024 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Oct 15, 2022 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Aug 24, 2021 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Aug 24, 2021 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 24, 2021 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 13, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 21, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 13, 2018 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 22, 2016 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 8, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2015 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 21, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2015 PUBO
NOTIFICATION PROCESSED BY IB
May 2, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 15, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 15, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 31, 2015 PREV
ASSIGNED TO LIE
Mar 30, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 12, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 12, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 12, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 12, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2015 TROA
REFUSAL PROCESSED BY IB
Jan 4, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 15, 2014 RFCS
REFUSAL PROCESSED BY MPU
Dec 15, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 12, 2014 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 12, 2014 MAFR
NON-FINAL ACTION WRITTEN
Dec 11, 2014 CNRT
ASSIGNED TO EXAMINER
Dec 8, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2014 REPR